423 related articles for article (PubMed ID: 27008205)
1. Prostate cancer: from Gleason scoring to prognostic grade grouping.
Montironi R; Santoni M; Mazzucchelli R; Burattini L; Berardi R; Galosi AB; Cheng L; Lopez-Beltran A; Briganti A; Montorsi F; Scarpelli M
Expert Rev Anticancer Ther; 2016; 16(4):433-40. PubMed ID: 27008205
[TBL] [Abstract][Full Text] [Related]
2. International Society of Urological Pathology (ISUP) grading of prostate cancer - An ISUP consensus on contemporary grading.
Egevad L; Delahunt B; Srigley JR; Samaratunga H
APMIS; 2016 Jun; 124(6):433-5. PubMed ID: 27150257
[TBL] [Abstract][Full Text] [Related]
3. SOCS3 Immunohistochemical Expression Seems to Support the 2005 and 2014 International Society of Urological Pathology (ISUP) Modified Gleason Grading System.
Pierconti F; Martini M; Cenci T; Petrone GL; Ricci R; Sacco E; Bassi PF; Larocca LM
Prostate; 2017 May; 77(6):597-603. PubMed ID: 28144985
[TBL] [Abstract][Full Text] [Related]
4. Controversial issues in Gleason and International Society of Urological Pathology (ISUP) prostate cancer grading: proposed recommendations for international implementation.
Srigley JR; Delahunt B; Samaratunga H; Billis A; Cheng L; Clouston D; Evans A; Furusato B; Kench J; Leite K; MacLennan G; Moch H; Pan CC; Rioux-Leclercq N; Ro J; Shanks J; Shen S; Tsuzuki T; Varma M; Wheeler T; Yaxley J; Egevad L
Pathology; 2019 Aug; 51(5):463-473. PubMed ID: 31279442
[TBL] [Abstract][Full Text] [Related]
5. From Gleason to International Society of Urological Pathology (ISUP) grading of prostate cancer.
Samaratunga H; Delahunt B; Yaxley J; Srigley JR; Egevad L
Scand J Urol; 2016 Oct; 50(5):325-9. PubMed ID: 27415753
[TBL] [Abstract][Full Text] [Related]
6. Prostate cancer glands with cribriform architecture and with glomeruloid features should be considered as Gleason pattern 4 and not pattern 3.
Minardi D; Mazzucchelli R; Scarpelli M; Massari F; Ciccarese C; Lopez-Beltran A; Cheng L; Montironi R
Future Oncol; 2016 Jun; 12(12):1431-3. PubMed ID: 27189718
[No Abstract] [Full Text] [Related]
7. Validation of International Society of Urological Pathology (ISUP) grading for prostatic adenocarcinoma in thin core biopsies using TROG 03.04 'RADAR' trial clinical data.
Delahunt B; Egevad L; Srigley JR; Steigler A; Murray JD; Atkinson C; Matthews J; Duchesne G; Spry NA; Christie D; Joseph D; Attia J; Denham JW
Pathology; 2015 Oct; 47(6):520-5. PubMed ID: 26325671
[TBL] [Abstract][Full Text] [Related]
8. Contemporary Gleason Grading of Prostatic Carcinoma: An Update With Discussion on Practical Issues to Implement the 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma.
Epstein JI; Amin MB; Reuter VE; Humphrey PA
Am J Surg Pathol; 2017 Apr; 41(4):e1-e7. PubMed ID: 28177964
[TBL] [Abstract][Full Text] [Related]
9. Implications of the International Society of Urological Pathology modified Gleason grading system.
Egevad L; Mazzucchelli R; Montironi R
Arch Pathol Lab Med; 2012 Apr; 136(4):426-34. PubMed ID: 22458905
[TBL] [Abstract][Full Text] [Related]
10. The prognostic significance of the 2014 International Society of Urological Pathology (ISUP) grading system for prostate cancer.
Samaratunga H; Delahunt B; Gianduzzo T; Coughlin G; Duffy D; LeFevre I; Johannsen S; Egevad L; Yaxley J
Pathology; 2015 Oct; 47(6):515-9. PubMed ID: 26325670
[TBL] [Abstract][Full Text] [Related]
11. Contemporary Gleason grading and novel Grade Groups in clinical practice.
Magi-Galluzzi C; Montironi R; Epstein JI
Curr Opin Urol; 2016 Sep; 26(5):488-92. PubMed ID: 27308734
[TBL] [Abstract][Full Text] [Related]
12. The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System.
Epstein JI; Egevad L; Amin MB; Delahunt B; Srigley JR; Humphrey PA;
Am J Surg Pathol; 2016 Feb; 40(2):244-52. PubMed ID: 26492179
[TBL] [Abstract][Full Text] [Related]
13. Gleason grading: past, present and future.
Delahunt B; Miller RJ; Srigley JR; Evans AJ; Samaratunga H
Histopathology; 2012 Jan; 60(1):75-86. PubMed ID: 22212079
[TBL] [Abstract][Full Text] [Related]
14. Changes in prostate cancer grading: Including a new patient-centric grading system.
Kryvenko ON; Epstein JI
Prostate; 2016 Apr; 76(5):427-33. PubMed ID: 26709152
[TBL] [Abstract][Full Text] [Related]
15. [The 2014 consensus conference of the ISUP on Gleason grading of prostatic carcinoma].
Kristiansen G; Egevad L; Amin M; Delahunt B; Srigley JR; Humphrey PA; Epstein JI;
Pathologe; 2016 Feb; 37(1):17-26. PubMed ID: 26809207
[TBL] [Abstract][Full Text] [Related]
16. Gleason and Fuhrman no longer make the grade.
Delahunt B; Egevad L; Samaratunga H; Martignoni G; Nacey JN; Srigley JR
Histopathology; 2016 Mar; 68(4):475-81. PubMed ID: 26266664
[TBL] [Abstract][Full Text] [Related]
17. Impact on the clinical outcome of prostate cancer by the 2005 international society of urological pathology modified Gleason grading system.
Dong F; Wang C; Farris AB; Wu S; Lee H; Olumi AF; McDougal WS; Young RH; Wu CL
Am J Surg Pathol; 2012 Jun; 36(6):838-43. PubMed ID: 22592143
[TBL] [Abstract][Full Text] [Related]
18. Future-proofing Gleason Grading: What to Call Gleason 6 Prostate Cancer?
Loeb S; Montorsi F; Catto JW
Eur Urol; 2015 Jul; 68(1):1-2. PubMed ID: 25769986
[TBL] [Abstract][Full Text] [Related]
19. The impact of the 2005 international society of urological pathology consensus conference on standard Gleason grading of prostatic carcinoma in needle biopsies.
Billis A; Guimaraes MS; Freitas LL; Meirelles L; Magna LA; Ferreira U
J Urol; 2008 Aug; 180(2):548-52; discussion 552-3. PubMed ID: 18550106
[TBL] [Abstract][Full Text] [Related]
20. Morphologic Updates in Prostate Pathology.
Adeniran AJ; Humphrey PA
Surg Pathol Clin; 2015 Dec; 8(4):539-60. PubMed ID: 26612214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]